White Owl Capital Partners

White Owl Capital Partners is an early-stage investment firm founded in 2007 and based in New York, focusing primarily on the technology and energy sectors. The firm typically invests between $500,000 and $3 million in technology ventures, while its investments in the energy sector range from $5 million to $20 million. Through these investments, White Owl Capital Partners aims to support innovative companies that contribute to advancements in their respective fields.

David Mars

Partner

15 past transactions

Brim Financial

Series B in 2021
Brim Financial Inc. issues non-banking credit cards. The company offers reward cards, credit cards, and travel cards to customers. The company was formerly known as KREDITShare Inc. and changed its name to Brim Financial Inc. in September, 2017. The company was founded in 2015 and is based in Toronto, Canada.

BESE

Venture Round in 2020
BESE Inc. is a digital media platform that focuses on cultural storytelling to highlight untold narratives reflective of contemporary America. Established in 2017 and headquartered in Los Angeles, California, the company targets millennial and Gen-Z audiences by offering multi-format content that is accessible across various social and digital channels. By reshaping the cultural narrative, BESE aims to provide users with the opportunity to engage with diverse stories and share their own experiences, thereby fostering a more inclusive dialogue in today’s media landscape.

TurnCare

Series A in 2017
TurnCare, Inc. manufactures pressure injury mitigation system to prevent pressure ulcers. The company offers Q2 System, a perfusion enhancement system that monitors chamber pressures, adjusts the application of pressure to create non-alternating spaces, and responds to movement from the patient. Its product helps to diminish perfusion due to pressure-induced capillary compression. The company was founded in 2011 and is based in Palo Alto, California.

Velano Vascular

Series B in 2017
Velano Vascular, Inc. is a medical device company based in San Francisco, California, that specializes in needle-free vascular access devices for blood collection. Its primary product, PIVO, is a single-use, sterile device that connects to indwelling peripheral IV lines to facilitate blood draws, significantly reducing the need for multiple needle sticks and minimizing central line access complications. Founded by a patient and a physician, Velano Vascular aims to alleviate the stress and anxiety patients often experience during blood draws in hospital settings. The device enhances safety and efficiency for healthcare providers while prioritizing patient comfort by reducing pain and discomfort associated with traditional blood collection methods. The company collaborates with leading hospital systems and organizations focused on patient-centered care and is supported by various investment partners.

Mass Appeal

Series A in 2017
Mass Appeal Media, Inc. is a multifaceted media company that produces and develops documentaries, scripted series, and unscripted formats for the film and television industry. Founded in 1996 and headquartered in New York, it has evolved from its origins as a graffiti magazine into a prominent publisher of urban lifestyle content. The company creates and publishes music, digital video, and editorial content, while also specializing in the production of premium advertising and branded content. Mass Appeal designs and executes marketing campaigns for global brands, reflecting a rich cultural heritage that spans music, art, and fashion. Its unique perspective aims to document the cultural convergence of these elements, engaging opinion leaders and trendsetters in contemporary conversations.

AdvisorConnect

Venture Round in 2017
AdvisorConnect is a sales acceleration platform for financial advisors, insurance agents, and the enterprise. Powered by an AI-driven Network Navigator and leveraging Cognitive Experience Design, AdvisorConnect automates advisor workflow and provides network-based analytics to drive product, marketing, and content strategies in real-time.

DotAlign

Seed Round in 2016
DotAlign, Inc. is a New York-based technology company that specializes in relationship intelligence and inbox productivity solutions tailored for corporate environments, particularly investment banks and private equity firms. The platform enhances CRM and email workflows by assessing the strength of professional relationships within an organization and providing insights into who knows whom. It automatically extracts and analyzes information from various data sources, including email, calendar, contacts, and LinkedIn, to identify key relationships, track communication, and highlight important contacts that may be neglected. By analyzing data directly on the user's device, DotAlign addresses compliance and privacy concerns. Founded in 2009 and originally named OpSpark Inc., the company rebranded to DotAlign in 2012.

dosist

Seed Round in 2016
Dosist is a health and wellness company specializing in cannabis-based therapies delivered through proprietary vaporizing dose-pens. Founded in 2016 in California, originally named "hmbldt," the company emphasizes precise dosage to ensure safe and effective use of its products, which are intended for adults aged 21 and older. Dosist's innovative dose-controlled technology allows users to experience the benefits of cannabinoid-based therapy in a consistent and predictable manner. The company has gained recognition for its contributions to the industry, being named one of TIME Magazine's Top 25 Inventions of 2016 and a finalist for Fast Company's World Changing Ideas Awards. With a focus on dosage, Dosist aims to redefine the cannabis experience for consumers seeking natural plant-based therapies.

Vigilant Biosciences

Series B in 2016
Vigilant Biosciences, Inc. is a medical technology company based in Fort Lauderdale, Florida, focused on the early detection and intervention of oral cancer. Founded in 2011, the company develops non-invasive screening solutions, particularly through its OncAlert product line, which includes point-of-care and lab-based tests designed to be simple, accurate, and cost-effective. The tests utilize patented technology to measure a combination of biomarkers associated with oral cancer, specifically through an oral rinse procedure that is easy for patients and healthcare practitioners to administer. Key products include the OncAlert Oral Cancer RAPID Test, the OncAlert Oral Cancer LAB Test, and the OraMark Test. These products have received CE Mark certification and are available in select international markets, with continued plans for availability in the United States through a CLIA certified laboratory. Vigilant Biosciences aims to empower healthcare providers to improve patient outcomes through earlier cancer detection.

Velano Vascular

Series A in 2016
Velano Vascular, Inc. is a medical device company based in San Francisco, California, that specializes in needle-free vascular access devices for blood collection. Its primary product, PIVO, is a single-use, sterile device that connects to indwelling peripheral IV lines to facilitate blood draws, significantly reducing the need for multiple needle sticks and minimizing central line access complications. Founded by a patient and a physician, Velano Vascular aims to alleviate the stress and anxiety patients often experience during blood draws in hospital settings. The device enhances safety and efficiency for healthcare providers while prioritizing patient comfort by reducing pain and discomfort associated with traditional blood collection methods. The company collaborates with leading hospital systems and organizations focused on patient-centered care and is supported by various investment partners.

Vigilant Biosciences

Series B in 2015
Vigilant Biosciences, Inc. is a medical technology company based in Fort Lauderdale, Florida, focused on the early detection and intervention of oral cancer. Founded in 2011, the company develops non-invasive screening solutions, particularly through its OncAlert product line, which includes point-of-care and lab-based tests designed to be simple, accurate, and cost-effective. The tests utilize patented technology to measure a combination of biomarkers associated with oral cancer, specifically through an oral rinse procedure that is easy for patients and healthcare practitioners to administer. Key products include the OncAlert Oral Cancer RAPID Test, the OncAlert Oral Cancer LAB Test, and the OraMark Test. These products have received CE Mark certification and are available in select international markets, with continued plans for availability in the United States through a CLIA certified laboratory. Vigilant Biosciences aims to empower healthcare providers to improve patient outcomes through earlier cancer detection.

Velano Vascular

Series A in 2015
Velano Vascular, Inc. is a medical device company based in San Francisco, California, that specializes in needle-free vascular access devices for blood collection. Its primary product, PIVO, is a single-use, sterile device that connects to indwelling peripheral IV lines to facilitate blood draws, significantly reducing the need for multiple needle sticks and minimizing central line access complications. Founded by a patient and a physician, Velano Vascular aims to alleviate the stress and anxiety patients often experience during blood draws in hospital settings. The device enhances safety and efficiency for healthcare providers while prioritizing patient comfort by reducing pain and discomfort associated with traditional blood collection methods. The company collaborates with leading hospital systems and organizations focused on patient-centered care and is supported by various investment partners.

Cronos Group

Seed Round in 2015
Cronos Group is a cannabinoid company based in Toronto, Canada, operating in both the United States and internationally. The company is engaged in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for medical and adult-use markets. It offers a diverse range of products, including hemp-derived supplements and cosmetics, distributed through various channels such as ecommerce, retail, and hospitality partnerships. Cronos Group's brand portfolio features PEACE NATURALS, which serves as a global wellness platform, along with adult-use brands COVE and Spinach, and hemp-derived CBD brands Lord Jones and PEACE+. The company is committed to operating within Health Canada's regulatory framework for medical cannabis.

Mass Appeal

Seed Round in 2013
Mass Appeal Media, Inc. is a multifaceted media company that produces and develops documentaries, scripted series, and unscripted formats for the film and television industry. Founded in 1996 and headquartered in New York, it has evolved from its origins as a graffiti magazine into a prominent publisher of urban lifestyle content. The company creates and publishes music, digital video, and editorial content, while also specializing in the production of premium advertising and branded content. Mass Appeal designs and executes marketing campaigns for global brands, reflecting a rich cultural heritage that spans music, art, and fashion. Its unique perspective aims to document the cultural convergence of these elements, engaging opinion leaders and trendsetters in contemporary conversations.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.